SCHEMBL23968261

SCHEMBL23968261

O=C1CCC(N2Cc3ccccc3C2O)C(=O)N1Cc1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 1/20 0.45
POLB P06746 1/20 0.45
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
ALDH1A1 P00352 5/20 0.42
GAA P10253 3/20 0.42
HPGD P15428 3/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
STAT6 P42226 1/20 0.42
MT-CO2 P00403 2/20 0.41
ALOX5 P09917 2/20 0.41
KDM4E B2RXH2 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
ME1 P48163 1/20 0.40
ALOX15 P16050 1/20 0.40
TSHR P16473 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23919165 0.80 ADORA2A (0.54) ADORA2APOLBMEN1KMT2AALDH1A1
SCHEMBL22541331 0.80 HDAC1 (0.34) ALDH1A1GAAHPGDCYP1A2CYP3A4
SCHEMBL23968143 0.79 SRD5A1 (0.41) KMT2AALDH1A1HPGDKDM4EALOX15
SCHEMBL24654323 0.78 ALDH1A1 (0.43) MEN1KMT2AALDH1A1GAAHPGD
SCHEMBL16446966 0.75 KMT2A (0.57) POLBMEN1KMT2AALDH1A1GAA
SCHEMBL16446964 0.75 KMT2A (0.57) POLBMEN1KMT2AALDH1A1GAA
SCHEMBL20128652 0.75 CRBN (0.52) ADORA2APOLBMEN1KMT2AALDH1A1
SCHEMBL20153856 0.73 ALDH1A1 (0.44) MEN1KMT2AALDH1A1GAAHPGD
SCHEMBL22565302 0.73 HDAC6 (0.33) ALDH1A1GAA
SCHEMBL4120260 0.72 ALDH1A1 (0.50) POLBMEN1KMT2AALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11161841-B2 Modulators of proteolysis and associated methods of use ARVINAS OPERATIONS, INC. (US) 2021-11-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11161841-B2 Modulators of proteolysis and associated methods of use MDM2, CRBN, VHL ADORA2A 3397/4885POLB 2694/4885MEN1 2058/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.